Henry K. Sze
Hong Kong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert Opinion.
Journal: Clinical genitourinary cancer
Published: November 19, 2023
Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma-Exploration for Achieving Optimal 10-Year Therapeutic Ratio.
Journal: International journal of radiation oncology, biology, physics
Published: January 05, 2018
Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study).
Journal: Oral oncology
Published: October 05, 2017
Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma.
Journal: International journal of radiation oncology, biology, physics
Published: July 21, 2017
Differences in clinical outcome between docetaxel and abiraterone acetate as the first-line treatment in chemo-naïve metastatic castration-resistant prostate cancer patients with or without the ineligible clinical factors of the COU-AA-302 study.
Journal: Prostate international
Published: June 07, 2017
Chemotherapy for Nasopharyngeal Carcinoma - Current Recommendation and Controversies.
Journal: Hematology/oncology clinics of North America
Published: November 17, 2015
Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
Journal: Cancer
Published: July 23, 2015
Last Updated: 09/26/2026